首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Medicine >Clinicopathologic significance and survival of TIP30 expression in laryngeal squamous cell carcinoma
【2h】

Clinicopathologic significance and survival of TIP30 expression in laryngeal squamous cell carcinoma

机译:TIP30在喉鳞状细胞癌中的表达及其临床意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: The expression and clinical significance of TIP30 and p53 in laryngeal squamous cell carcinoma (LSCC) have not been investigated. Method: We determined immunohistochemically the expression of TIP30 and p53 in surgical specimens from 105 patients with LSCC. Survivals were estimated using the Kaplan-Meier method. Results: TIP30 protein expression in LSCC patients was significantly less in tumor tissues than that of adjacent normal tissues (46.7% vs. 79.0%), while p53 protein expression was significantly increased in LSCC (15.2% vs. 63.8%) compared with adjacent normal tissues. The TIP30 expression levels were also significantly correlated with tumor stage, differentiation, and the presence of lymph nodes. The expression of TIP30 was significantly negatively correlated with that of p53 (r = -0.249, P = 0.010). LSCC patients with lower expression level of TIP30 had a significantly higher recurrence and worse overall survival than those with elevated TIP30 expression (P = 0.014 and P = 0.040, respectively). Furthermore, multivariable analysis found that patients with high expression of TIP30 had a greater than approximately 2.2-fold increased risk for death overall or recurrence than those with low expression of TIP30, supporting that down-regulation of TIP30 expression in tumors may involve in development and progression and predict poor prognosis of patients with LSCC. Conclusion: Our results may suggest that down-expression of TIP30 is closely related to carcinogenesis, progression, biological behavior, and prognosis of LSCC.
机译:背景:尚未研究TIP30和p53在喉鳞状细胞癌(LSCC)中的表达及其临床意义。方法:我们用免疫组织化学方法测定了105例LSCC患者手术标本中TIP30和p53的表达。使用Kaplan-Meier方法估算存活率。结果:LSCC患者的TIP30蛋白表达在肿瘤组织中显着低于邻近正常组织(46.7%对79.0%),而LSCC中p53蛋白表达与邻近正常组织相比显着增加(15.2%对63.8%)。组织。 TIP30表达水平也与肿瘤分期,分化和淋巴结的存在显着相关。 TIP30的表达与p53呈显着负相关(r = -0.249,P = 0.010)。 TIP30表达水平较低的LSCC患者与TIP30表达水平升高的患者相比,复发率和总生存率均显着较高(分别为P = 0.014和P = 0.040)。此外,多变量分析发现,高表达TIP30的患者的总体死亡或复发风险比低表达TIP30的患者高约2.2倍,这支持了肿瘤中TIP30表达的下调可能与肿瘤的发生和发展有关。进展并预测LSCC患者的不良预后。结论:我们的结果可能表明TIP30的下表达与LSCC的发生,发展,生物学行为和预后密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号